Home/Filings/5/0001388410-20-000025
5//SEC Filing

Gorlach Jorn 5

Accession 0001388410-20-000025

CIK 0001388410other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 6:35 PM ET

Size

13.8 KB

Accession

0001388410-20-000025

Insider Transaction Report

Form 5
Period: 2019-12-31
Gorlach Jorn
Director10% Owner
Transactions
  • Award

    WARRANTS

    2019-07-25+419,9986,299,306 total(indirect: By Hamburg Investment Co)
    Exercise: $0.10From: 2019-07-25Exp: 2024-07-25COMMON STOCK (419,998 underlying)
  • Award

    COMMON STOCK (RESTRICTED)

    2019-07-25+1,151,44320,229,557 total(indirect: By LLC)
  • Disposition to Issuer

    WARRANTS (PREFERRED SERIES B)

    2019-01-2315,0003,770,893 total(indirect: By Hamburg Investment Co)
    Exercise: $0.25From: 2017-01-23Exp: 2019-01-23COMMON STOCK (300,000 underlying)
  • Award

    COMMON STOCK (RESTRICTED)

    2019-07-25+229,36820,458,925 total(indirect: By Hamburg Investment Co)
  • Award

    WARRANTS

    2019-07-25+2,108,4155,879,308 total(indirect: By LLC)
    Exercise: $0.25From: 2019-07-25Exp: 2024-07-25COMMON STOCK (2,108,415 underlying)
Footnotes (2)
  • [F1]Expiration of warrants issued in connection with Series B Convertible Preferred Stock.
  • [F2]Issued pursuant to Settlement Agreement / Promissory Note exchange dated July 25, 2019.

Issuer

PARALLAX HEALTH SCIENCES, INC.

CIK 0001388410

Entity typeother

Related Parties

1
  • filerCIK 0001596048

Filing Metadata

Form type
5
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:35 PM ET
Size
13.8 KB